<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>Fetal Medicine Foundation</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/" />
    <link rel="self" type="application/atom+xml" href="http://www.fetalmedicine.com/fmf/atom.xml" />
    <id>tag:www.fetalmedicine.com,2008-10-30:/fmf//1</id>
    <updated>2010-02-13T16:43:50Z</updated>
    
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type Pro 4.21-en</generator>

<entry>
    <title>Videos of fetal defects</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/online-education/06-videos-of-fetal-defects/videos-of-fetal-defects/" />
    <id>tag:www.fetalmedicine.com,2010:/fmf//1.222</id>

    <published>2010-02-07T20:19:01Z</published>
    <updated>2010-02-13T16:43:50Z</updated>

    <summary>This section contains a selection of videos illustrating normal fetal anatomy and fetal defects. In order to view the videos you need to select the system (e.g. Brain) and then the specific condition (e.g. Holoprosencephaly). If you want to leave...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="06 Videos of fetal defects" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>This section contains a selection of videos illustrating normal fetal anatomy and fetal defects.</p>

<p>In order to view the videos you need to select the system (e.g. Brain) and then the specific condition (e.g. Holoprosencephaly). </p>

<p>If you want to leave any comments or view comments from other users you can use the links at the bottom right of each page.</p>

<p>We would be grateful to receive videos of interesting cases and your contribution will be acknowledged. Please save your video in windows media video format and forward to <a href="mailto:nicola.persico@gmail.com">nicola.persico@gmail.com</a>.</p>

<p>If you want to view the videos please click <a href="https://courses.fetalmedicine.com/fmf/do_course/10">here.</a> </p>

<h4>Acknowledgments:</h4>


<ul>
<li>Director: Kypros Nicolaides</li>
<li>Co-ordinator: Nicola Persico</li>
<li>Video editing: Jader Cruz, Yuval Gielchinsky</li>
</ul>

]]>
        
    </content>
</entry>

<entry>
    <title>2009</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/research/research-publications/publications-2009/" />
    <id>tag:www.fetalmedicine.com,2010:/fmf//1.220</id>

    <published>2010-01-23T15:56:21Z</published>
    <updated>2010-01-23T17:18:38Z</updated>

    <summary> Akbar SA, Khawaja NP, Brown PR, Tayyeb R, Bamfo J, Nicolaides KH. Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations. Acta Obstet Gynecol Scand 2009;88:606-11. Akolekar R, Casagrandi D,...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="01 Research publications" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[
<ol>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19308748?ordinalpos=12&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akbar <span class="caps">SA,</span> Khawaja <span class="caps">NP,</span> Brown <span class="caps">PR,</span> Tayyeb R, Bamfo J, Nicolaides <span class="caps">KH.</span></a> Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations. Acta Obstet Gynecol Scand 2009;88:606-11.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19565609?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides <span class="caps">KH.</span></a> Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn 2009;29:934-8. </li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19499513?ordinalpos=5&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akolekar R, Casagrandi D, Skyfta E, Ahmed <span class="caps">AA,</span> Nicolaides <span class="caps">KH.</span></a> Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn 2009;29:847-51.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19412915?ordinalpos=8&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akolekar R, Minekawa R, Veduta A, Romero <span class="caps">XC,</span> Nicolaides <span class="caps">KH.</span></a> Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn 2009;29(8):753-60.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19777530?ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides <span class="caps">KH.</span></a> Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn. 2009;29:1103-8.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19776595?ordinalpos=4&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides <span class="caps">KH.</span></a> Maternal serum activin at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther. 2009;25:320-7.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19929992?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=1">Anderson <span class="caps">JM,</span> Savvidou <span class="caps">MD,</span> Kaihura C, McEniery <span class="caps">CM,</span> Nicolaides <span class="caps">KH.</span></a> Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus. Diabet Med. 2009;26:1135-40.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19326370?ordinalpos=11&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Benavides-Serralde A, Hernández-Andrade E, Fernández-Delgado J, Plasencia W, Scheier M, Crispi F, Figueras F, Nicolaides <span class="caps">KH,</span> Gratacós E.</a> Three-dimensional sonographic calculation of the volume of intracranial structures in growth-restricted and appropriate-for-gestational age fetuses. Ultrasound Obstet Gynecol 2009;33:530-7.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19705402?ordinalpos=5&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling <span class="caps">KS,</span> Nicolaides <span class="caps">KH.</span></a> Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol 2009;34:249-52.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20026875?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=2">Chiu <span class="caps">RW,</span> Sun H, Akolekar R, Clouser C, Lee C, McKernan K, Zhou D, Nicolaides <span class="caps">KH,</span> Lo <span class="caps">YM.</span></a> Maternal Plasma <span class="caps">DNA</span> Analysis with Massively Parallel Sequencing by Ligation for Noninvasive Prenatal Diagnosis of Trisomy 21. Clin Chem 2009 [Epub ahead of print]</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19288535?ordinalpos=14&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Cowans <span class="caps">NJ,</span> Stamatopoulou A, Maiz N, Spencer K, Nicolaides <span class="caps">KH.</span></a> The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and <span class="caps">PAPP</span>-A MoM in normal and trisomy 21 pregnancies. Prenat Diagn 2009;29:578-81.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/18845492?ordinalpos=9&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Deprest <span class="caps">JA,</span> Flemmer <span class="caps">AW,</span> Gratacos E, Nicolaides K.</a> Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. Semin Fetal Neonatal Med 2009;14:8-13.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19125386?ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Deprest <span class="caps">JA,</span> Hyett <span class="caps">JA,</span> Flake <span class="caps">AW,</span> Nicolaides K, Gratacos E.</a> Current controversies in prenatal diagnosis 4: Should fetal surgery be done in all cases of severe diaphragmatic hernia? Prenat Diagn 2009;29:15-19.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19559323?ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Deprest <span class="caps">JA,</span> Gratacos E, Nicolaides K, Done E, Van Mieghem T, Gucciardo L, Claus F, Debeer A, Allegaert K, Reiss I, Tibboel D.</a> Changing perspectives on the perinatal management of isolated congenital diaphragmatic hernia in Europe. Clin Perinatol 2009;36:329-47.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19790100?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Hernandez-Andrade E, Crispi F, Benavides-Serralde <span class="caps">JA,</span> Plasencia W, Diesel <span class="caps">HF,</span> Eixarch E, Acosta-Rojas R, Figueras F, Nicolaides K, Gratacós E.</a> Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth-restricted fetuses. Ultrasound Obstet Gynecol 2009;34:430-6.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/18844275?ordinalpos=4&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Jani <span class="caps">JC,</span> Benachi A, Nicolaides <span class="caps">KH,</span> Allegaert K, Gratacós E, Mazkereth R, Matis J, Tibboel D, Van Heijst A, Storme L, Rousseau V, Greenough A, Deprest JA; the Antenatal <span class="caps">CDH</span> Registry group.</a> Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study. Ultrasound Obstet Gynecol 2009;33:64-9.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19658113?ordinalpos=6&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Jani <span class="caps">JC,</span> Nicolaides <span class="caps">KH,</span> Gratacós E, Valencia <span class="caps">CM,</span> Doné E, Martinez <span class="caps">JM,</span> Gucciardo L, Cruz R, Deprest <span class="caps">JA.</span></a> Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol 2009;34:304-10.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19031473?ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Kagan <span class="caps">KO,</span> Valencia C, Livanos P, Wright D, Nicolaides <span class="caps">KH.</span></a> Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:18-22</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19248005?ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Kagan <span class="caps">KO,</span> Cicero S, Staboulidou I, Wright D, Nicolaides <span class="caps">KH.</span></a> Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:259-64.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19526452?ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Kagan <span class="caps">KO,</span> Etchegaray A, Zhou Y, Wright D, Nicolaides <span class="caps">KH.</span></a> Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009;34:14-8.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19408250?ordinalpos=9&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Kagan <span class="caps">KO,</span> Wright D, Etchegaray A, Zhou Y, Nicolaides <span class="caps">KH.</span></a> Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009;33:657-64.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19465544?ordinalpos=7&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Kaihura C, Savvidou <span class="caps">MD,</span> Anderson <span class="caps">JM,</span> McEniery <span class="caps">CM,</span> Nicolaides <span class="caps">KH.</span></a> Maternal arterial stiffness in pregnancies affected by pre-eclampsia. Am J Physiol Heart Circ Physiol 2009;297:H759-64.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19469907?ordinalpos=6&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Konstantinidou <span class="caps">AE,</span> Kaminopetros P, Sifakis S, Fokaefs T, Gougoudi E, Prezerakou M, Kikidi K, Patsouris E, Nicolaides <span class="caps">KH.</span></a> Intrauterine laser photocoagulation for congenital lung malformations: late histopathological effects of a novel therapeutic intervention. Histopathology 2009;54(7):904-7.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19173240?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Leal <span class="caps">AM,</span> Poon <span class="caps">LC,</span> Frisova V, Veduta A, Nicolaides <span class="caps">KH.</span></a> First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33:135-141</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19338027?ordinalpos=10&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Maiz N, Valencia C, Kagan <span class="caps">KO,</span> Wright D, Nicolaides <span class="caps">KH.</span></a> Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:512-7.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19305331?ordinalpos=13&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Maiz N, Staboulidou I, Leal <span class="caps">AM,</span> Minekawa R, Nicolaides <span class="caps">KH.</span></a> Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies. Obstet Gynecol. 2009;113:860-5.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19090499?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Maiz N, Valencia C, Plasencia W, Nicolaides <span class="caps">KH.</span></a> First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33:23-33.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19516271?ordinalpos=4&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Kametas <span class="caps">NA,</span> Chelemen T, Leal A, Nicolaides <span class="caps">KH.</span></a> Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2009;24(2):104-10.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19273739?ordinalpos=17&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Kametas <span class="caps">NA,</span> Maiz N, Akolekar R, Nicolaides <span class="caps">KH.</span></a> First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-8.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19242924?ordinalpos=19&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides <span class="caps">KH.</span></a> First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome. Prenat Diagn 2009;29:553-9.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19285649?ordinalpos=15&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Chelemen T, Minekawa R, Frisova V, Nicolaides <span class="caps">KH.</span></a> Maternal serum <span class="caps">ADAM12 </span>(A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Am J Obstet Gynecol 2009;200:508.e1-6.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19644947?ordinalpos=7&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Poon <span class="caps">LC,</span> Staboulidou I, Maiz N, Plasencia W, Nicolaides <span class="caps">KH.</span></a> Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol. 2009;34:142-8.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19827052?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=4">Poon <span class="caps">LC,</span> Karagiannis G, Leal A, Romero <span class="caps">XC,</span> Nicolaides <span class="caps">KH.</span></a> Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks. Ultrasound Obstet Gynecol. 2009;34:497-502.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19220238?ordinalpos=5&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Savvidou M, Akolekar R, Zaragoza E, Poon L, Nicolaides K.</a> First trimester urinary placental growth factor and development of pre-eclampsia. <span class="caps">BJOG</span> 2009;116:643-7.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19631923?ordinalpos=8&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Sifakis S, Zaravinos A, Maiz N, Spandidos <span class="caps">DA,</span> Nicolaides <span class="caps">KH.</span></a> First-trimester maternal plasma cell-free fetal <span class="caps">DNA </span>and preeclampsia. Am J Obstet Gynecol. 2009;201:472.e1-7</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19231524?ordinalpos=20&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Sinha <span class="caps">CK,</span> Islam S, Patel S, Nicolaides K, Greenough A, Davenport M.</a> Congenital diaphragmatic hernia: prognostic indices in the fetal endoluminal tracheal occlusion era. J Pediatr Surg 2009;44:312-6.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19842139?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=3">Spencer K, Staboulidou I, De Jesus Cruz J, Karagiannis G, Nicolaides <span class="caps">KH.</span></a> Maternal serum screening marker levels in women with a previous aneuploidy pregnancy. Prenat Diagn. 2009;29:1242-3.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19776597?ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Staboulidou I, Galindo A, Maiz N, Karagiannis G, Nicolaides <span class="caps">KH.</span></a> First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects. Fetal Diagn Ther 2009;25:336-9.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19892844?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=2">Tsui <span class="caps">NB,</span> Akolekar R, Chiu <span class="caps">RW,</span> Chow <span class="caps">KC,</span> Leung <span class="caps">TY,</span> Lau <span class="caps">TK,</span> Nicolaides <span class="caps">KH,</span> Lo <span class="caps">YM.</span></a> Synergy of Total <span class="caps">PLAC4 RNA</span> Concentration and Measurement of the <span class="caps">RNA</span> Single-Nucleotide Polymorphism Allelic Ratio for the Noninvasive Prenatal Detection of Trisomy 21. Clin Chem. 2009;56(1):73-81.</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19277983?ordinalpos=16&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Zaragoza E, Akolekar R, Poon <span class="caps">LC,</span> Pepes S, Nicolaides <span class="caps">KH.</span></a> Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 2009;33:382-6.</li>
</ol>



<p><a href="#topofpage">Return to top of page</a></p>]]>
        
    </content>
</entry>

<entry>
    <title>Mauritania</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/04-mauritania/mauritania/" />
    <id>tag:www.fetalmedicine.com,2010:/fmf//1.218</id>

    <published>2010-01-20T16:00:43Z</published>
    <updated>2010-01-21T14:07:16Z</updated>

    <summary>The Islamic Republic of Mauritania is a sub-Saharan African country with a population of about 3.3 million. It is inhabited by Arab Berbers in the North and Black Africans in the south. Mauritania was a French colony and became an...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="04 Mauritania" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>The Islamic Republic of Mauritania is a sub-Saharan African country with a population of about 3.3 million. It is inhabited by Arab Berbers in the North and Black Africans in the south. Mauritania was a French colony and became an independent country in 1960. The country's political landscape has been marked by a series of coups and democratic transitions, and has attracted international attention for its wide spread practice of slavery.</p>

<p>Life expectancy is 58 years. Maternal death occurs in about 1 in 100 pregnancies (less than 1 in 10,000 in developed countries) and 1 in 8 babies born alive die by the age of 5 years. There are less than 10 obstetricians for the whole contry and most deliveries are performed by unqualified and often illiterate birth attendants.</p>

<p>As part of the Look for Life project a team from the Fetal Medicine Foundation visited Nouakchott and Atar in October 2009, to assess the situation concerning pregnancy care and to provide basic training in obstetric ultrasound to a group of midwives and nurses. </p>]]>
        <![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Mauritania_map.jpg" src="http://www.fetalmedicine.com/fmf/Mauritania_map.jpg" width="250" height="272" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<h3>Ultrasound training in Mauritania, 2009</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Mauritania_training1.jpg" src="http://www.fetalmedicine.com/fmf/Mauritania_training1.jpg" width="355" height="237" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Mauritania_training2.jpg" src="http://www.fetalmedicine.com/fmf/Mauritania_training2.jpg" width="355" height="237" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p>Dr Catalina De Paco from the Fetal Medicine Foundation training midwives to perform ultrasound scans</p>]]>
    </content>
</entry>

<entry>
    <title>Rwanda</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/03-rwanda/rwanda/" />
    <id>tag:www.fetalmedicine.com,2010:/fmf//1.217</id>

    <published>2010-01-20T14:35:16Z</published>
    <updated>2010-01-21T14:14:41Z</updated>

    <summary>Rwanda, is a country situated on the east central part of Africa with a population of 10.5 million inhabited predominantly by Hutu (80%) and Tutsi ethnic groups. Historically these groups had lived together in harmony but in 1994, following the...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="03 Rwanda" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>Rwanda, is a country situated on the east central part of Africa with a population of 10.5 million inhabited predominantly by Hutu (80%) and Tutsi ethnic groups. Historically these groups had lived together in harmony but in 1994, following the violent death of the president of Rwanda, the country witnessed a violent ethnic massacre in which some 800,000 Tutsis were killed within 3 months. A democratically elected government is now in power.</p>

<p>Life expectancy is about 50 years. Maternal death occurs in about 1 in 130 pregnancies (less than 1 in 10,000 in developed countries) and 1 in 5 babies born alive die by the age of 5 years.</p>

<p>As part of the Look for Life project a team from the Fetal Medicine Foundation visited Rwanda in January 2009 to provide training in obstetric ultrasound for a group of obstetricians, midwives and nurses.<br />
 <br />
The Foundation has offered scholarships to doctors and midwives from Rwanda to come to London for extensive training in fetal medicine and the first trainee will be arriving in 2010.</p>]]>
        <![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Rwanda_map.jpg" src="http://www.fetalmedicine.com/fmf/Rwanda_map.jpg" width="252" height="272" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<h3>Ultrasound training in Kigali, 2009</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Rwanda_training1.JPG" src="http://www.fetalmedicine.com/fmf/Rwanda_training1.JPG" width="355" height="266" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Rwanda_training2.JPG" src="http://www.fetalmedicine.com/fmf/Rwanda_training2.JPG" width="355" height="266" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p>Dr Nerea Maiz and Dr Nicola Persico from the Fetal Medicine Foundation training doctors to perform ultrasound scans</p>]]>
    </content>
</entry>

<entry>
    <title>Iraq</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/06-iraq/iraq/" />
    <id>tag:www.fetalmedicine.com,2010:/fmf//1.216</id>

    <published>2010-01-20T12:31:11Z</published>
    <updated>2010-01-20T19:29:13Z</updated>

    <summary>Sky News reported recently on the concerns raised by families in Fallujah, Iraq, where newborn babies appear to be suffering from increased rates of deformities since the 2004 Iraq war. They fear that exposure to chemicals used during the conflict...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="06 Iraq" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>Sky News reported recently on the concerns raised by families in Fallujah, Iraq, where newborn babies appear to be suffering from increased rates of deformities since the 2004 Iraq war. They fear that exposure to chemicals used during the conflict may have caused this increase but the lack of detailed records makes this claim difficult to assess objectively.</p>

<p>In the light of this report The Fetal Medicine Foundation has decided to offer scholarships to obstetricians from Fallujah to receive training in London. The doctors will then return to Fallujah to improve the care of pregnant women and ultimately establish a recording system which may enable them to determine the underlying causes for the birth deformities.</p>

<p>The first doctor is already in London and training in Fetal Medicine.</p>

<p>For more on this Sky News report and a video click <a href="http://news.sky.com/skynews/Home/World-News/Iraq-Doctors-Offered-Scolarships-To-Study-Birth-Defects-In-Fallujah-After-Sky-News-Report/Article/20080621318608?lid=ARTICLE_1318608_Iraq%20Doctors%20Offered%20Scolarships%20To%20Study%20Birth%20Defects%20In%20Fallujah%20After%20Sky%20News%20Report&amp;lpos=searchresults" target="_blank">here</a></p>]]>
        <![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Iraq_map.jpg" src="http://www.fetalmedicine.com/fmf/Iraq_map.jpg" width="274" height="274" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>]]>
    </content>
</entry>

<entry>
    <title>Transfers to the congress venue</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/courses-congress/conferences/8th-world-congress/8th-fmf-world-congress/" />
    <id>tag:www.fetalmedicine.com,2009:/fmf//1.212</id>

    <published>2009-04-14T10:48:21Z</published>
    <updated>2009-05-05T23:32:11Z</updated>

    <summary>Tranfers to the congress venue from the nearest airports can be booked by contacting a travel agency as indicated below. When booking please inform them that you are a delegate of the 8th World Congress to secure the prices below....</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="8th FMF World Congress - Slovenia 2009" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>Tranfers to the congress venue from the nearest airports can be booked by contacting a travel agency as indicated below. When booking please inform them that you are a delegate of the 8th World Congress to secure the prices below.</p>

<h3>Contact details</h3>

<p>Sun-tours d.o.o.<br />
Grand hotel Bernardin<br />
Obala 2 - 6320 Portorose</p>

<p>Contact person: Boris Rolc<br />
e-mail: <a href="mailto:%73%75%6E%74%6F%75%72%73%40%73%69%6F%6C%2E%6E%65%74">suntours@siol.net</a><br />
Web: <a href= "http://www.sun-tours.si" target="_blank">www.sun-tours.si</a><br />
Tel: +386- 56 748 510<br />
Fax: +386- 56 746 411<br />
Emergency telephone number: +386-40 710 560 </p>

<h4>One way transfers to Portorose</h4>


<ul>
<li>Trieste airport: 20 Euros per person</li>
<li>Ljubljana airport: 30 Euros per person</li>
<li>Venice airport: 40 Euros per person</li>
<li>Treviso airport: 45 Euros per person</li>
</ul>



<p>&nbsp;</p>

<p>In order to group delegates arriving from different airports there could be a maximum waiting time of 1 hour.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Flights to Trieste</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/courses-congress/conferences/8th-world-congress/flights-to-trieste/" />
    <id>tag:www.fetalmedicine.com,2009:/fmf//1.214</id>

    <published>2009-04-13T15:12:17Z</published>
    <updated>2009-04-14T15:49:47Z</updated>

    <summary>Athens Alitalia - via Rome Olympic Airways - via Rome Olympic Airways - via Munich Lufthansa Airways - via Munich Brussels Lufthansa Airways - via Munich Bucharest Alitalia - via Rome Lufthansa Airways - via Munich Copenhagen Air Dolomite -...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="8th FMF World Congress - Slovenia 2009" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h4>Athens</h4>


<ul>
<li>Alitalia - via Rome</li>
<li>Olympic Airways - via Rome</li>
<li>Olympic Airways - via Munich</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Brussels</h4>


<ul>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Bucharest</h4>


<ul>
<li>Alitalia - via Rome</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Copenhagen</h4>


<ul>
<li>Air Dolomite - via Munich</li>
</ul>



<h4>Dublin</h4>


<ul>
<li>Air France - via Paris</li>
</ul>



<h4>Frankfurt</h4>


<ul>
<li>Air Dolomite - via Munich</li>
<li>Air France - via Paris</li>
<li>Air One - via Rome</li>
<li>Brit Air - via Paris</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Istanbul</h4>


<ul>
<li>Air One - via Rome</li>
<li>Alitalia - via Rome</li>
<li>Air Dolomite - via Munich</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Kieve</h4>


<ul>
<li>Air One - via Rome</li>
</ul>



<h4>Larnaca</h4>


<ul>
<li>Alitalia - via Rome</li>
</ul>



<h4>London</h4>


<ul>
<li>Ryanair - direct flight</li>
</ul>



<h4>Madrid</h4>


<ul>
<li>Alitalia - via Rome</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Moscow</h4>


<ul>
<li>Air One - via Rome</li>
</ul>



<h4>Munich</h4>


<ul>
<li>Air Dolomite - direct flight</li>
<li>Lufthansa Airways -  direct flight</li>
<li>United Airlines -  direct flight</li>
</ul>



<h4>Paris</h4>


<ul>
<li>Brit Air - direct flight</li>
</ul>



<h4>Rome</h4>


<ul>
<li>Air One - direct flight</li>
<li>Alitalia - direct flight</li>
</ul>



<h4>Vienna</h4>


<ul>
<li>Alitalia - via Rome</li>
<li>Brit Air - via Paris</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Warsaw</h4>


<ul>
<li>Air One - via Rome</li>
<li>Alitalia - via Rome</li>
</ul>



<h4>Zurich</h4>


<ul>
<li>Air Dolomite - via Munich</li>
<li>Lufthansa Airways - via Munich</li>
</ul>

]]>
        
    </content>
</entry>

<entry>
    <title>Flights to Llubljana</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/courses-congress/conferences/8th-world-congress/flights-to-llubljana/" />
    <id>tag:www.fetalmedicine.com,2009:/fmf//1.213</id>

    <published>2009-04-12T20:31:08Z</published>
    <updated>2009-04-14T18:51:23Z</updated>

    <summary>Amsterdam Adria Airways - direct flight Athens Adria Airways - direct flight Austrian Airways - via Vienna Lufthansa Airways - via Munich Malev Airways - via Budapest SwissAir Airways - via Zurich Barcelona Adria Airways - direct flight Adria Airways...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="8th FMF World Congress - Slovenia 2009" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h4>Amsterdam</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Athens</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Austrian Airways - via Vienna</li>
<li>Lufthansa Airways - via Munich</li>
<li>Malev Airways - via Budapest</li>
<li>SwissAir Airways - via Zurich</li>
</ul>



<h4>Barcelona</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Adria Airways - via Brussels</li>
<li>Adria Airways - via Frankfurt</li>
<li>Czech Airline - via Prague</li>
<li>Lufthansa Airways - via Munich</li>
</ul>



<h4>Brussels</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Bucharest</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Budapest</h4>


<ul>
<li>Malev Airways - direct flight</li>
</ul>



<h4>Copenhagen</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Malev Airways - via Budapest</li>
</ul>



<h4>Dublin</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Adria Airways - via Frankfurt</li>
<li>Lufthansa Airways - via Frankfurt</li>
<li>Air France (Proteus) - via Paris</li>
</ul>



<h4>Frankfurt</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Istanbul</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Turkish Airline - direct flight</li>
</ul>



<h4>Kieve</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Czech Airline - via Prague</li>
</ul>



<h4>Larnaca</h4>


<ul>
<li>Adria Airways - from Athens</li>
<li>Austrian Airways - via Vienna</li>
<li>Lufthansa Airways -  via Frankfurt</li>
<li>Malev Airways - via Budapest</li>
</ul>



<h4>London</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Ryanair - direct flight</li>
</ul>



<h4>Madrid</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Manchester</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Moscow</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Munich</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Lufthansa Airways -  direct flight</li>
</ul>



<h4>Paris</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Air France - direct flight</li>
</ul>



<h4>Prague</h4>


<ul>
<li>Czech Airlines - direct flight</li>
</ul>



<h4>Stockholm</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Vienna</h4>


<ul>
<li>Adria Airways - direct flight</li>
</ul>



<h4>Warsaw</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li><span class="caps">LOT </span>- direct flight</li>
</ul>



<h4>Zurich</h4>


<ul>
<li>Adria Airways - direct flight</li>
<li>Swiss Air - direct flight</li>
</ul>

]]>
        
    </content>
</entry>

<entry>
    <title>Cervical assessment</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/online-education/05-cervical-assessment/cervical-assessment-1/" />
    <id>tag:www.fetalmedicine.com,2009:/fmf//1.207</id>

    <published>2009-01-05T23:39:51Z</published>
    <updated>2010-02-23T16:27:26Z</updated>

    <summary>Internet course This internet based course explains the technique of measuring cervical length and the clinical applications of this measurement. The course is compulsory for all sonographers wishing to obtain the FMF Certificate of competence in cervical assessment. The course...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="05 Cervical assessment" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h3>Internet course</h3>

<p>This internet based course explains the technique of measuring cervical length and the clinical applications of this measurement.</p>

<p>The course is compulsory for all sonographers wishing to obtain the <span class="caps">FMF</span> Certificate of competence in cervical assessment. The course may also be useful for patients wishing to be better informed on the value of cervical assessment in pregnancy.</p>


<ul>
<li>The course is free of charge</li>
</ul>




<ul>
<li>It lasts for about 30 minutes</li>
</ul>




<ul>
<li>If you are a <b>patient</b> and you want to attend the course please click <a href="https://courses.fetalmedicine.com/fmf/do_course/5">here.</a></li>
</ul>




<ul>
<li>If you are a <b>health care practitioner</b> and you want to obtain the <span class="caps">FMF</span> Certificate of competence in cervical assessment you need to be registered with the <span class="caps">FMF </span>before attending the course:</li>
</ul>




<ul>
<li>If you already have a <span class="caps">FMF</span> ID please login <a href="https://courses.fetalmedicine.com/fmf/do_course/5?user=login">here.</a></li>
</ul>




<ul>
<li>If you are not already registered with the <span class="caps">FMF </span>then please register <a href="https://courses.fetalmedicine.com/fmf/do_course/5?user=register">here.</a> </li>
</ul>

]]>
        <![CDATA[<h3>Internet course on cervical assessment</h3>

<h5>Compulsory for <span class="caps">FMF</span> Certificate of competence in cervical assessment</h5>

<h5>Available in 18 languages.</h5>

<h5>Free of charge.</h5>

<h5>List of registrants.</h5>

<p>To view the list of health care professionals who have completed the internet based course on cervical assessment please click <a href="https://courses.fetalmedicine.com/lists/web/5" onclick="window.open(this.href,'Specialists','menubar=0,location=0,status=0,scrollbars=1,width=800,height=600');return false;">here.</a></p>

<iframe src="https://courses.fetalmedicine.com/lists/summary/5" width="100%" height="900" frameborder="0"><br />
<p>your browser does not support iframes</p>
</iframe>]]>
    </content>
</entry>

<entry>
    <title>India</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/05-india/india/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.206</id>

    <published>2008-12-21T13:43:09Z</published>
    <updated>2010-02-19T01:50:47Z</updated>

    <summary>In 2008 Professor Kypros Nicolaides visited India as a guest of the Federation of Obstetricians and Gynecologists of India and gave the FOGSI oration on Advances in Fetal Medicine. During this visit he had discussions with the president and general...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="05 India" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>In 2008 Professor Kypros Nicolaides visited India as a guest of the Federation of Obstetricians and Gynecologists of India and gave the <span class="caps">FOGSI </span>oration on Advances in Fetal Medicine. During this visit he had discussions with the president and general secretary of <span class="caps">FOGSI </span>(Dr NC Malhotra and Dr CN Purandare) and agreed that The <span class="caps">FMF </span>will sponsor four 2-year <span class="caps">FMF</span>-FOGSI training fellowships in Fetal Medicine, under his supervision in London.</p>

<p>The <span class="caps">FMF </span>will also collaborate with <span class="caps">FOGSI </span>in the organisation of at least six <span class="caps">FMF</span>-FOGSI training courses in Fetal Medicine per year to be held in different parts of India.</p>

<h4><span class="caps">FMF </span>fellowships for doctors from India</h4>

<p>The minimum requirements for a <span class="caps">FMF </span>training fellowship are that the candidates have <span class="caps">GMC </span>registration and it would be preferable if they apply within three years of obtaining a postgraduate qualification (MD, <span class="caps">DNB, DGO</span>).</p>

<p>Applications for the <span class="caps">FMF</span>-FOGSI fellowships should be made to <span class="caps">FOGSI</span>/FMF representative In India:</p>

<p><b>Dr Anita Kaul</b><br />
Fetal Medicine Unit<br />
Gate No 7<br />
Indraprastha Apollo Hospitals<br />
New Delhi 110076, India</p>

Tel : 91-11 -29873018 or 26925858<br />
Mobile : 91-98111-00511<br />
Email : <a href="mailto:%61%6E%69%74%61%5F%6B%40%61%70%6F%6C%6C%6F%68%6F%73%70%69%74%61%6C%73%2E%63%6F%6D">anita_k@apollohospitals.com</a><br />
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>]]>
        <![CDATA[<h3><span class="caps">FOGSI </span>congress, India 2008</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="India-1.jpg" src="http://www.fetalmedicine.com/fmf/India-1.jpg" width="355" height="235" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="India-2.jpg" src="http://www.fetalmedicine.com/fmf/India-2.jpg" width="355" height="235" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="India-3.jpg" src="http://www.fetalmedicine.com/fmf/India-3.jpg" width="355" height="237" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>]]>
    </content>
</entry>

<entry>
    <title>Liberia</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/02-liberia/liberia-a-poor-country-on/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.205</id>

    <published>2008-12-21T13:36:51Z</published>
    <updated>2010-01-21T14:15:53Z</updated>

    <summary>Liberia, a poor country on the west coast of Africa with a population of about 3.8 million, was founded as a colony in the 1820&apos;s by freed slaves from the United States. In 1847 it became the first Republic in...</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="02 Liberia" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>Liberia, a poor country on the west coast of Africa with a population of about 3.8 million, was founded as a colony in the 1820's by freed slaves from the United States. In 1847 it became the first Republic in Africa. A recurrent theme in the country's history was the hostility between the Americo-Liberian minority along the coast and the natives of the interior. Civil wars between 1989 and 2003 resulted in the death of hundreds of thousands of people and devastation of the economy and infrastructure of the country. Democratic elections in 2006 brought to power President Ellen Johnson-Sirleaf, the first elected female head of state in Africa.</p>

<p>Life expectancy is only about 40 years and the average age of the population is 18 years. Maternal death occurs in about 1 in 100 pregnancies (less than 1 in 10,000 in developed countries) and 4 of 10 babies born alive die by the age of 5 years. The whole country has only six obstetricians.</p>

<p>As part of the Look for Life project a team from the Fetal Medicine Foundation visited Liberia in December 2008 to assess the situation concerning pregnancy care and to provide basic training in obstetric ultrasound for a group of Obstetricians, midwives and nurses. </p>

<p>The Foundation has offered scholarships to doctors from Liberia to come to London for extensive training in fetal medicine and the first trainee will be arriving in 2010.</p>

<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>]]>
        <![CDATA[<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Liberia_map_final.jpg" src="http://www.fetalmedicine.com/fmf/Liberia_map_final.jpg" width="247" height="274" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<h3>Ultrasound training in Monrovia, 2008</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Liberia training3.jpg" src="http://www.fetalmedicine.com/fmf/Liberia%20training3.jpg" width="355" height="266" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Liberia_training2.JPG" src="http://www.fetalmedicine.com/fmf/Liberia_training2.JPG" width="355" height="266" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<p>Dr Nicola Persico from the Fetal Medicine Foundation training midwives to perform ultrasound scans</p>]]>
    </content>
</entry>

<entry>
    <title></title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/h4-please-login-below/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.203</id>

    <published>2008-12-19T13:14:39Z</published>
    <updated>2008-12-19T13:14:58Z</updated>

    <summary><![CDATA[Please login below. &nbsp; Name: Password: &nbsp;...]]></summary>
    <author>
        <name>FMF</name>
        
    </author>
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h4>Please login below.</h4>

<p>&nbsp;</p>

 <form action="https://courses.astraia.com/login/login" method="post">       <label for="name">Name:</label>
        <input id="name" name="name" type="text" />          <label for="password">Password:</label>
        <input id="password" name="password" type="password" />         <input class="submit" name="commit" type="submit" value="Login" />

    </form>

<p>&nbsp;</p>]]>
        
    </content>
</entry>

<entry>
    <title></title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/training-certification/certificates-of-competence/own-page-1/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.202</id>

    <published>2008-12-08T21:28:35Z</published>
    <updated>2009-02-05T09:21:02Z</updated>

    <summary><![CDATA[Please login below. &nbsp; Name: Password: &nbsp;...]]></summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="01 Certificates of competence" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h4>Please login below.</h4>

<p>&nbsp;</p>

 <form action="https://courses.fetalmedicine.com/login/login" method="post">       <label for="name">Name:</label>
        <input id="name" name="name" type="text" />          <label for="password">Password:</label>
        <input id="password" name="password" type="password" />         <input class="submit" name="commit" type="submit" value="Login" />

    </form>

<p>&nbsp;</p>]]>
        
    </content>
</entry>

<entry>
    <title>Introduction</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/look-for-life/01-introduction/introduction-5/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.134</id>

    <published>2008-12-01T17:02:55Z</published>
    <updated>2010-01-20T16:50:22Z</updated>

    <summary>Ultrasound examination plays an important role in the improvement of pregnancy outcome both for the mother and the baby. Unfortunately this technology is at present confined to developed countries or the well off of the population in some developing countries....</summary>
    <author>
        <name>FMF</name>
        
    </author>
    
        <category term="01 Introduction" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<p>Ultrasound examination plays an important role in the improvement of pregnancy outcome both for the mother and the baby. Unfortunately this technology is at present confined to developed countries or the well off of the population in some developing countries.</p>

<p>According to statistics from the World Health Organization more than half a million women die every year in the world as a result of a complication related to pregnancy or delivery. More than 99% of these deaths are in underdeveloped or developing countries. </p>

<p>The <b>Look for Life</b> campaign by the Fetal Medicine Foundation aims to reduce maternal and perinatal mortality in underdeveloped and developing countries through training of local healthcare providers in the use of ultrasound and the creation of fetal medicine centres to improve the care of pregnant women.</p>]]>
        <![CDATA[<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Look for life.jpg" src="http://www.fetalmedicine.com/fmf/Look%20for%20life.jpg" width="355" height="266" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>]]>
    </content>
</entry>

<entry>
    <title>Nuchal translucency</title>
    <link rel="alternate" type="text/html" href="http://www.fetalmedicine.com/fmf/training-certification/certificates-of-competence/11-13-week-scan/nuchal/" />
    <id>tag:www.fetalmedicine.com,2008:/fmf//1.125</id>

    <published>2008-11-25T23:09:36Z</published>
    <updated>2010-02-19T01:53:03Z</updated>

    <summary>FMF Certificate of competence in the measurement of nuchal translucency Nuchal translucency (NT) is the sonographic appearance of a collection of fluid under the skin behind the fetal neck in the first-trimester of pregnancy. The term translucency is used, irrespective...</summary>
    <author>
        <name>Matt Carey</name>
        
    </author>
    
        <category term="The 11-13 weeks scan" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.fetalmedicine.com/fmf/">
        <![CDATA[<h3><span class="caps">FMF</span> Certificate of competence in the measurement of nuchal translucency</h3>

<p>Nuchal translucency (NT) is the sonographic appearance of a collection of fluid under the skin behind the fetal neck in the first-trimester of pregnancy. The term translucency is used, irrespective of whether it is septated or not and whether it is confined to the neck or envelopes the whole fetus. In fetuses with chromosomal abnormalities, cardiac defects and many genetic syndromes the NT thickness is increased.</p>

<p>The <span class="caps">FMF </span>has set up a process for certification in the measurement of fetal NT to ensure that those performing this ultrasound examination have been adequately trained to do so and that high standards of performance are maintained by continuous education and audit.</p>

<p>Once the <span class="caps">FMF</span> Certificate of competence in the measurement of NT has been obtained, the doctor/sonographer will be entitled to receive free of charge the <span class="caps">FMF </span>software for the calculation of risk of chromosomal abnormalities by a combination of maternal age, fetal NT and first-trimester maternal serum free β-hCG and <span class="caps">PAPP</span>-A. The only condition for ongoing certification and use of the software is provision of NT data and images by the sonographer for the purposes of audit. </p>

<h4>Requirements for Certification in the measurement of nuchal translucency</h4>

<p>The requirements for certification are:</p>

<p>1.  Attendance of the internet based course on the <a href="http://www.fetalmedicine.com/fmf/online-education/01-11-136-week-scan/">11-13 weeks scan</a>. This course is intended for all medical personnel involved in antenatal care and is not confined to those performing the 11-13 weeks scan. <br />
2.  Submission of a logbook of 3 images demonstrating the measurement of <span class="caps">NT.</span></p>

<h4>Protocol for measurement of nuchal translucency</h4>


<ul>
<li>The gestational period must be 11 to 13 weeks and six days.</li>
<li>The fetal crown-rump length should be between 45 and 84mm.</li>
<li>The magnification of the image should be such that the fetal head and thorax occupy the whole screen.</li>
<li>A mid-sagittal view of the face should be obtained. This is defined by the presence of the echogenic tip of the nose and rectangular shape of the palate anteriorly, the translucent diencephalon in the centre and the nuchal membrane posteriorly. Minor deviations from the exact midline plane would cause non-visualization of the tip of the nose and visibility of the zygomatic process of the maxilla.</li>
<li>The fetus should be in a neutral position, with the head in line with the spine. When the fetal neck is hyperextended the measurement can be falsely increased and when the neck is flexed, the measurement can be falsely decreased.</li>
<li>Care must be taken to distinguish between fetal skin and amnion.</li>
<li>The widest part of translucency must always be measured.</li>
<li>Measurements should be taken with the inner border of the horizontal line of the callipers placed ON the line that defines the nuchal translucency thickness - the crossbar of the calliper should be such that it is hardly visible as it merges with the white line of the border, not in the nuchal fluid.</li>
<li>In magnifying the image (pre or post freeze zoom) it is important to turn the gain down. This avoids the mistake of placing the calliper on the fuzzy edge of the line which causes an underestimate of the nuchal measurement.</li>
<li>During the scan more than one measurement must be taken and the maximum one that meets all the above criteria should be recorded in the database.</li>
<li>The umbilical cord may be round the fetal neck in about 5% of cases and this finding may produce a falsely increased <span class="caps">NT.</span> In such cases, the measurements of NT above and below the cord are different and, in the calculation of risk, it is more appropriate to use the average of the two measurements</li>
</ul>



<h4>Quality review and ongoing Certification in nuchal translucency</h4>


<ul>
<li>Each sonographer must submit NT data and 3 images for audit 12 months after obtaining the <span class="caps">FMF</span> Certificate of competence in NT and the <span class="caps">FMF </span>software for the calculation of risks. In addition to the <span class="caps">FMF </span>audit, all sonographers are encouraged to perform their own internal quality assurance on a monthly basis by examining their NT distribution using the automated audit module incorporated within the <span class="caps">FMF </span>risk calculation software.</li>
<li>The audit involves assessment of the distribution of NT measurements of each sonographer and examination of their images. Sonographers passing their audit will be re-audited and re-licensed on an annual basis thereafter. The NT distribution cannot be assessed if fewer than 30 scans have been performed, but in this situation an individual can still pass their audit if their images are satisfactory.</li>
<li>If the NT distribution falls outside the satisfactory range advice will be given on how to improve the NT technique, based on the review of images. The name of the sonographer will be removed from the <span class="caps">FMF </span>website list of holders of the Certificate of competence in <span class="caps">NT.</span> A new audit will be carried out in 3 months (please see audit policies on your own <span class="caps">FMF </span>page) and the sonographer will only be reinstated on the <span class="caps">FMF </span>website list once the audit is considered satisfactory. However, if in the new audit the standard of the sonographer has not improved then their <span class="caps">FMF </span>software license will be revoked. In such case the sonographer will need to be retrained and apply for recertification by attending the <span class="caps">FMF </span>internet based course on the 11-13 weeks scan and submitting the appropriate logbook of images.</li>
</ul>



<h4>Submission of logbook</h4>

<p>Please login to upload your images:</p>

<p>&nbsp;</p>

        <form action="https://courses.fetalmedicine.com/login/login" method="post">       <label for="name">Name:</label>
        <input id="name" name="name" type="text" />          <label for="password">Password:</label>
        <input id="password" name="password" type="password" />         <input class="submit" name="commit" type="submit" value="Login" />

    </form>

<p>&nbsp;</p>

<p>Alternatively, send your completed logbook to:</p>

<p>The 11-13 weeks scan: Nuchal translucency<br />
The Fetal Medicine Foundation<br />
137 Harley Street<br />
London, <span class="caps">W1G</span> 6BG</p>

<h4>Holders of the <span class="caps">FMF</span> Certificate in the measurement of nuchal translucency</h4>

<p>Many thousands of sonographers have been awarded the <span class="caps">FMF</span> Certificate of competence in the measurement of <span class="caps">NT.</span> These sonographers have attended the internet based course on the 11-13 weeks scan and have submitted satisfactory images demonstrating their competence in the measurement of fetal <span class="caps">NT.</span> To view the list of these sonographers please click <a href="https://courses.fetalmedicine.com/lists?course=1" onclick="window.open(this.href,'Specialists','menubar=0,location=0,status=0,scrollbars=1,width=800,height=600');return false;">here.</a></p>

<p>Many (but not all) sonographers, in addition to obtaining the certificate of competence in the measurement of <span class="caps">NT, </span>have submitted to the <span class="caps">FMF </span>their NT measurements and representative images for audit, and were found to be satisfactory. To view the list of these sonographers please click <a href="https://courses.fetalmedicine.com/lists/specialist" onclick="window.open(this.href,'Specialists','menubar=0,location=0,status=0,scrollbars=1,width=800,height=600');return false;">here.</a></p>

<p><a href="#topofpage">Return to top of page</a></p>]]>
        <![CDATA[<p>&nbsp;</p>

<h3>Midsagittal view of the face</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Midsagittal.JPG" src="http://www.fetalmedicine.com/fmf/Midsagittal.JPG" width="355" height="347" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<h3>Normal nuchal translucency</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Normal NT.jpg" src="http://www.fetalmedicine.com/fmf/Normal%20NT.jpg" width="355" height="280" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>

<h3>Increased nuchal translucency</h3>

<p><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><img alt="Increased NT.jpg" src="http://www.fetalmedicine.com/fmf/Increased%20NT.jpg" width="355" height="298" class="mt-image-center" style="text-align: center; display: block; margin: 0 auto 20px;" /></span></p>]]>
    </content>
</entry>

</feed>
